A leading company focused on virtual transformation.
The U. S. Food and Drug Administration issued an emergency authorization for convalescent plasma to treat COVID-19, a resolution that follows President Donald Trump’s un proliferated claims that a dark “deep state” had sought to block the remedy until the end of this year’s election.
Speaking at the White House on Sunday, Trump said the approval marked “a breakthrough” in the coronavirus remedy.
But, as reported through the Associated Press, the FDA argues that plasma use, taken from those who have recovered from coronavirus and injected those who are still fighting it, “should not be considered as a new popular treatment. for the remedy of patients with COVID-19. “
Emergency authorization is not a full approval, but it reduces bureaucratic barriers to the deployment of the remedy, which has already been attempted in some 53,000 patients in the United States; However, it is not yet known whether the remedy actually works.
“Without a randomized controlled trial, it’s very difficult to be sure that what you have is significant,” Dr. W said. Ian Lipkin, who ran a clinical trial of the remedy at Columbia University, told the New York Times before. Month. .
But Trump’s leadership has pressured the FDA to authorize the plasma remedy, seeking a victory in combat opposing COVID-19 before the 2020 election, Dr. Luciana Borio, a public fitness expert who served on the National Security Council under Trump, told The Times. that approving the remedy would be a sign that the FDA was “giving in to political pressure. “
Before Sunday’s announcement, Trump tweeted that “the deep state, or whoever, at the FDA” hinders efforts to find a cure for COVID-19. “Clearly, they hope to delay the reaction until November 3,” he said without proof.
CNBC reported Sunday that the Trump administration will also accelerate the approval of a coronavirus vaccine before the November election, which may echo the efforts of Russian President Vladimir Putin to claim victory before clinical trials are completed.
Do you have any new advice? Send a message to this reporter: cdavis@insider. com
Get the latest research on the economic and advertising effect on Business Insider Intelligence coronavirus on how COVID-19 affects industries.